CAS: 1384426-12-3
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
2-Propenethioamide, 3-(3-bromo-4,5-dihydroxyphenyl)-N-[(3,4,5-trihydroxyphenyl)methyl]-, (2E)- REF: IN-DA00195NCAS: 1384426-12-3 | 98% | A consultar | Lun 02 Dic 24 | |
NT157 REF: TM-T4605CAS: 1384426-12-3 | 97.55% | 54,00 €~807,00 € | Mar 10 Dic 24 | |
NT-157 REF: 3D-FN137703CAS: 1384426-12-3 | Min. 95% | A consultar | Lun 13 Ene 25 |
2-Propenethioamide, 3-(3-bromo-4,5-dihydroxyphenyl)-N-[(3,4,5-trihydroxyphenyl)methyl]-, (2E)-
CAS:1384426-12-3
Fórmula:
C16H14BrNO5S
Pureza:
98%
Forma y color:
Solid
Peso molecular:
412.2551
Ref: IN-DA00195N
2mg | 155,00 € | ||
5mg | 219,00 € | ||
25mg | 613,00 € | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 2 de Diciembre de 2024
NT157
CAS:1384426-12-3
NT157, a small tyrphostin, inhibits IRS, IGF-1R, and STAT3 in TME, reducing cancer cell survival.
Fórmula:
C16H14BrNO5S
Pureza:
97.55%
Forma y color:
Solid
Peso molecular:
412.26
Ref: TM-T4605
1mg | 54,00 € | ||
5mg | 125,00 € | ||
10mg | 185,00 € | ||
25mg | 361,00 € | ||
50mg | 569,00 € | ||
100mg | 807,00 € | ||
1mL*10mM (DMSO) | 140,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
NT-157
CAS:1384426-12-3
NT-157 is a small-molecule drug that targets the JAK2 V617F mutation found in chronic myeloid …
Pureza:
Min. 95%
Ref: 3D-FN137703
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 13 de Enero de 2025